Duchenne Muscular Dystrophy Treatment Market: Is 2026 the Era of "Newborn Screening" for Universal Early Intervention?
In 2026, the market is witnessing the "Legislative Revolution" of universal newborn screening for Duchenne. In 2026, the market is identifying "Early Diagnostic Mandates" as a high-growth driver for the Duchenne Muscular Dystrophy Treatment Market, with over 30 U.S. states and several European nations now testing every male infant at birth. This 2026 movement is significant because it allows...
0 Commenti 0 condivisioni 130 Views 0 Anteprima